Better Late Than Never – Unpacking FDA’s Highly Anticipated (and Long Overdue) Draft Guidance on Diversity Action Plans By Mark A. Tobolowsky & Véronique Li, Senior Medical Device Regulation Expert & Sarah Wicks & Deborah L. Livornese —

https://www.thefdalawblog.com/2024/07/better-late-than-never-unpacking-fdas-highly-anticipated-and-long-overdue-draft-guidance-on-diversity-action-plans/?utm_source=rss&utm_medium=rss&utm_campaign=better-late-than-never-unpacking-fdas-highly-anticipated-and-long-overdue-draft-guidance-on-diversity-action-plans